Key result
A pharmaceutical care program for uncontrolled hypertension showed a trend for better BP control, with an adjusted 24-hour systolic BP difference of 3 mm Hg (95% CI -1 to 5) compared to control.
Why the study?
Does a pharmaceutical care program improve ambulatory blood pressure in patients with uncontrolled hypertension?
Population
71 patients with uncontrolled/resistant hypertension
Comparison
Pharmaceutical care program vs Control group
Design
RCT, randomized, double-blind
Follow-up
6 months
Authors
Loading...
Pharmaceutical care programs should not yet change hypertension management; leaves open modest benefits for larger trials.
RCT (n=71)
Double-blind
randomized
Does a pharmaceutical care program improve ambulatory blood pressure in patients with uncontrolled hypertension?
Effect estimate: Difference 3 mm Hg (24h systolic BP) (95% CI -1 to 5)
A pharmaceutical care program was feasible and showed a non-significant trend toward better ambulatory blood pressure control in patients with uncontrolled hypertension.
DeCastro et al. (2006) conducted an RCT in Uncontrolled hypertension (n=71). Pharmaceutical care program vs. Control group was evaluated on Change in ambulatory BP (ABP) between baseline and 6 months (Difference 3 mm Hg (24h systolic BP), 95% CI -1 to 5). A pharmaceutical care program for uncontrolled hypertension showed a trend for better BP control, with an adjusted 24-hour systolic BP difference of 3 mm Hg (95% CI -1 to 5) compared to control.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: